Related Experiment Video
Updated: Jun 15, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Pediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared
1Division of Rheumatology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, MC 4010, Cincinnati, OH 45229, USA.
Insights
Pediatric systemic lupus erythematosus (SLE) presents more acutely with higher mortality and organ damage compared to adult SLE. Unique pathways explaining these differences in pediatric lupus remain elusive.
Area of Science:
- Rheumatology
- Immunology
- Pediatric Medicine
Background:
- Complement deficiencies are linked to early-onset systemic lupus erythematosus (SLE).
- Significant variability exists in SLE disease phenotypes, particularly between pediatric and adult patients.
- The underlying physiological and genetic factors driving these phenotypic differences are not well understood.
Purpose of the Study:
- To highlight the distinct clinical presentation and outcomes of pediatric SLE compared to adult SLE.
- To underscore the need for further research into the unique pathways influencing pediatric SLE.
Main Methods:
- Comparative analysis of clinical data from pediatric and adult SLE patients.
- Review of existing literature on SLE pathophysiology and treatment.
Main Results:
- Children with SLE exhibit more acute illness, with greater frequency of renal, hematologic, and central nervous system involvement.
- Pediatric SLE patients have higher mortality rates and accrue more organ damage (renal, ocular, musculoskeletal) than adults.
- Adult SLE patients experience higher rates of cardiovascular mortality.
Conclusions:
- Pediatric SLE is a distinct clinical entity with more severe manifestations and poorer outcomes compared to adult SLE.
- Current understanding of SLE pathophysiology does not fully explain the observed differences in disease presentation and progression between age groups.
- Further investigation into unique pediatric SLE pathways is crucial for improving patient care and outcomes.
Abstract:
Some complement deficiencies predispose to systemic lupus erythematosus (SLE) early in life. Currently, there are no known unique physiologic or genetic pathways that can explain the variability in disease phenotypes. Children present with more acute illness and have more frequent renal, hematologic, and central nervous system involvement compared to adults with SLE. Almost all children require corticosteroids during the course of their disease; many are treated with immunosuppressive drugs. Mortality rates remain higher with pediatric SLE. Children and adolescents accrue more damage, especially in the renal, ocular and musculoskeletal organ systems. Conversely, cardiovascular mortality is more prevalent in adults with SLE.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Factors Affecting Drug Response: Overview
Drug Dosing: Infants and Children